NIH's malaria lab seeks contractors to conduct vaccine trials

The National Institutes of Health’s Laboratory of Malaria Immunology and Vaccinology (LMIV) recently began soliciting lab contractors who can conduct clinical trials on test vaccines.

New malaria vaccines are being created and developed regularly and need to be tested.

LMIV’s mission is to develop malaria vaccines first and foremost, but the LMIV also requires the assistance of contractors who can conduct trials to investigate the vaccines for initial safety, immunogenicity and biological impact.

The LMIV also may require that selected contractors conduct clinical studies of pathogenesis research to help further and facilitate vaccine development.

All trials and testing will be conducted at the National Institute of Allergy and Infectious Diseases, National Institutes of Health, in Rockville, Maryland.

The deadline to submit proposals for furnishing the supplies and/or services is 3 p.m. Eastern time on Feb. 19. Offers will be valid for 120 days, unless a different period is specified. The scheduled contract award date is Aug. 14.

The contracting office address is Office of Acquisitions, 5601 Fishers Lane, Third Floor, MSC 9821, Bethesda, Maryland, 20892.

The primary contact person is Alice Sobsey, and she can be reached at 240-669-5118 or alice.sobsey@nih.gov.

The secondary point of contact is Dixie Harper, and her contact information is 240-669-5119 or dixie.harper@nih.gov.

Organizations in this Story

National Institutes of Health

Want to get notified whenever we write about National Institutes of Health ?
Next time we write about National Institutes of Health, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.